» Articles » PMID: 18492816

Effect of Sulphation on the Oestrogen Agonist Activity of the Phytoestrogens Genistein and Daidzein in MCF-7 Human Breast Cancer Cells

Overview
Journal J Endocrinol
Specialty Endocrinology
Date 2008 May 22
PMID 18492816
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The phytoestrogens genistein, daidzein and the daidzein metabolite equol have been shown previously to possess oestrogen agonist activity. However, following consumption of soya diets, they are found in the body not only as aglycones but also as metabolites conjugated at their 4'- and 7-hydroxyl groups with sulphate. This paper describes the effects of monosulphation on the oestrogen agonist properties of these three phytoestrogens in MCF-7 human breast cancer cells in terms of their relative ability to compete with [(3)H]oestradiol for binding to oestrogen receptor (ER), to induce a stably transfected oestrogen-responsive reporter gene (ERE-CAT) and to stimulate cell growth. In no case did sulphation abolish activity. The 4'-sulphation of genistein reduced oestrogen agonist activity to a small extent in whole-cell assays but increased the relative binding affinity to ER. The 7-sulphation of genistein, and also of equol, reduced oestrogen agonist activity substantially in all assays. By contrast, the position of monosulphation of daidzein acted in an opposing manner on oestrogen agonist activity. Sulphation at the 4'-position of daidzein resulted in a modest reduction in oestrogen agonist activity but sulphation of daidzein at the 7-position resulted in an increase in oestrogen agonist activity. Molecular modelling and docking studies suggested that the inverse effects of sulphation could be explained by the binding of daidzein into the ligand-binding domain of the ER in the opposite orientation compared with genistein and equol. This is the first report of sulphation enhancing activity of an isoflavone and inverse effects of sulphation between individual phytoestrogens.

Citing Articles

The role of isoflavones in augmenting the effects of radiotherapy.

Ivashkevich A Front Oncol. 2023; 12:800562.

PMID: 36936272 PMC: 10016616. DOI: 10.3389/fonc.2022.800562.


Estrogenic in vitro evaluation of zearalenone and its phase I and II metabolites in combination with soy isoflavones.

Grgic D, Betschler A, Fruholz R, Novak B, Varga E, Marko D Arch Toxicol. 2022; 96(12):3385-3402.

PMID: 35986755 PMC: 9584851. DOI: 10.1007/s00204-022-03358-3.


Therapeutic Potential of Isoflavones with an Emphasis on Daidzein.

Alshehri M, Sharifi-Rad J, Herrera-Bravo J, Jara E, Salazar L, Kregiel D Oxid Med Cell Longev. 2021; 2021:6331630.

PMID: 34539970 PMC: 8448605. DOI: 10.1155/2021/6331630.


Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MS.

Liu L, Li H, Xu F, Wang H, Zhang Y, Liu G Molecules. 2020; 25(23).

PMID: 33256251 PMC: 7729672. DOI: 10.3390/molecules25235560.


Dietary Phenolics against Breast Cancer. A Critical Evidence-Based Review and Future Perspectives.

Avila-Galvez M, Gimenez-Bastida J, Espin J, Gonzalez-Sarrias A Int J Mol Sci. 2020; 21(16).

PMID: 32784973 PMC: 7461055. DOI: 10.3390/ijms21165718.


References
1.
Osborne C, Hobbs K, Trent J . Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 1987; 9(2):111-21. DOI: 10.1007/BF01807363. View

2.
Clarke D, Lloyd A, Botting N, Oldfield M, Needs P, Wiseman H . Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with [13C(3)]isoflavone internal standards. Anal Biochem. 2002; 309(1):158-72. DOI: 10.1016/s0003-2697(02)00275-0. View

3.
Matsumura A, Ghosh A, Pope G, Darbre P . Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol. 2005; 94(5):431-43. DOI: 10.1016/j.jsbmb.2004.12.041. View

4.
Dampier K, Hudson E, Howells L, Manson M, Walker R, Gescher A . Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer. 2001; 85(4):618-24. PMC: 2364092. DOI: 10.1054/bjoc.2001.1980. View

5.
Totta P, Acconcia F, Virgili F, Cassidy A, Weinberg P, Rimbach G . Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. J Nutr. 2005; 135(11):2687-93. DOI: 10.1093/jn/135.11.2687. View